"申し訳ございませんが、COVID-19感染拡大防止のため、面会を原則禁止とさせていただいております。詳しくはホームページをご覧ください。"

During the past decade, Mie University Hospital conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 23 clinical trials were completed, i.e. on average, 40.4% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 20 clinical trials were completed. i.e. 60.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mie University Hospital" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Eli Lilly and Company" with 8 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored and "Kyowa Kirin Co., Ltd." with 3 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mie University Hospital" #1 collaborator was "Chugai Pharmaceutical" with 3 trials as a collaborator, "Fiverings Co., Ltd." with 2 trials as a collaborator, "Mie University" with 2 trials as a collaborator, "Shionogi" with 2 trials as a collaborator and "Statcom Co. Ltd." with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Mie University Hospital" are "Psoriasis" (6 trials), "Crohn's Disease" (4 trials), "Fallopian Tube Cancer" (4 trials), "Ovarian Cancer" (4 trials) and "Ulcerative Colitis" (4 trials). Many other conditions were trialed in "Mie University Hospital" in a lesser frequency.

Most popular intervention types in "Mie University Hospital" are "Drug" (63 trials), "Biological" (8 trials), "Other" (6 trials), "Procedure" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Mirikizumab" (6 trials), "Sham Procedure" (6 trials), "Faricimab" (5 trials) and "Guselkumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Mie University Hospital" are 64 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mie University Hospital". undefined are not yet recruiting, 20 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Mie University Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Mie University Hospital, 7 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".